Celyad announces third quarter 2015 business update

Celyad announces third quarter 2015 business update

Celyad reports First Half 2015 financial results and operational progress

Celyad reports First Half 2015 financial results and operational progress

Celyad announces closing of its global offering

Celyad announces closing of its global offering

Celyad raises $100.1 million gross proceeds with NASDAQ IPO

Celyad raises $100.1 million gross proceeds with NASDAQ IPO

Celyad announces launch of proposed global offering

Celyad announces launch of proposed global offering

Celyad announces first quarter 2015 business update

Celyad announces first quarter 2015 business update

Celyad announces filing of registration statement in the United States for a proposed global offering

Celyad announces filing of registration statement in the United States for a proposed global offering

Cardio3 BioSciences Announces Results of Annual Shareholder Assembly 2015 and Confirmation of Name Change to Celyad

Cardio3 BioSciences Announces Results of Annual Shareholder Assembly 2015 and Confirmation of Name Change to Celyad

Cardio3 BioSciences announces intention to conduct a registered public offering in the United States

Cardio3 BioSciences announces intention to conduct a registered public offering in the United States

CArdio3 BioSciences Reports 2014 Fincancial and Operating Results

CArdio3 BioSciences Reports 2014 Fincancial and Operating Results

Cardio3 BioSciences successfully completes a €32 Million private placement

Cardio3 BioSciences successfully completes a €32 Million private placement

Cardio3 BioSciences to raise capital via a private placement of new shares

Cardio3 BioSciences to raise capital via a private placement of new shares